Fig. 1From: All-cause mortality risk in aged femoral intertrochanteric fracture patientsCumulative survival of Intertrochanteric fracture patients by gender (A), age (B), Charlson comorbidity index (C) and dosing zoledronic acid or not (D)Back to article page